BioCentury
ARTICLE | Company News

Plexcera licenses recombinant ceramidase from Mount Sinai

September 13, 2013 11:21 PM UTC

The Icahn School of Medicine at Mount Sinai Hospital (New York, N.Y.) granted Plexcera Therapeutics LLC (Vero Beach, Fla.) exclusive, worldwide rights to develop and commercialize recombinant human ac...